ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,597.25
0.10%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Humacyte Inc (HUMA)

  7. Humacyte Inc (HUMA) Noticias

HUMA

Humacyte (HUMA)

Humacyte Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HUMA
FechaHoraFuenteTítuloSímboloCompañía
08/03/202415:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:HUMAHumacyte Inc
04/03/202405:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HUMAHumacyte Inc
29/02/202415:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:HUMAHumacyte Inc
12/12/202315:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HUMAHumacyte Inc
09/11/202315:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HUMAHumacyte Inc
11/09/202319:03Dow Jones NewsStocks to Watch: Oracle, Acelyrin, HumacyteNASDAQ:HUMAHumacyte Inc
17/08/202315:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HUMAHumacyte Inc
31/07/202312:28Dow Jones NewsHumacyte Shares Rise 8% After Completing Enrollment in Phase 2/3 TrialNASDAQ:HUMAHumacyte Inc
16/06/202315:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HUMAHumacyte Inc
15/06/202315:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HUMAHumacyte Inc
09/06/202315:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:HUMAHumacyte Inc
08/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HUMAHumacyte Inc
24/05/202315:53Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:HUMAHumacyte Inc
12/05/202315:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HUMAHumacyte Inc
28/04/202305:45Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HUMAHumacyte Inc
24/03/202307:51Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HUMAHumacyte Inc
10/11/202209:30TipRanksAnalysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Humacyte (HUMA)NASDAQ:HUMAHumacyte Inc
19/09/202215:42Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HUMAHumacyte Inc
15/09/202205:33Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:HUMAHumacyte Inc
12/09/202205:31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:HUMAHumacyte Inc
09/09/202215:44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:HUMAHumacyte Inc
12/08/202211:25TipRanksHumacyte (HUMA) Gets a Buy from BTIGNASDAQ:HUMAHumacyte Inc
12/07/202204:36TipRanksBTIG Thinks Humacyte’s Stock is Going to RecoverNASDAQ:HUMAHumacyte Inc
04/04/202216:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(7) (424b7)NASDAQ:HUMAHumacyte Inc
29/03/202209:45TipRanksAnalysts Offer Insights on Healthcare Companies: AKOUOS (AKUS) and Humacyte (HUMA)NASDAQ:HUMAHumacyte Inc
14/02/202215:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:HUMAHumacyte Inc
09/02/202206:30GlobeNewswire Inc.Humacyte to Participate in Fireside Chat at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:HUMAHumacyte Inc
31/01/202206:30GlobeNewswire Inc.Humacyte Announces Clinical Case Series Demonstrating Potential of Human Acellular Vessel™ (HAV™) to Expand Opportunities for Limb Salvage in Multiple Complex Vascular Reconstruction ScenariosNASDAQ:HUMAHumacyte Inc
28/01/202208:15GlobeNewswire Inc.Humacyte Announces Preclinical Results of Small-Diameter Human Acellular Vessel™ (HAV™) in Coronary Artery Bypass GraftingNASDAQ:HUMAHumacyte Inc
06/01/202206:30GlobeNewswire Inc.Humacyte Announces Presentation of First Eight Expanded Access Cases Using Human Acellular Vessel™ (HAV) for Treatment of Critical Limb Ischemia at 46th Annual Winter Meeting of the Vascular and Endovascular Surgery SocietyNASDAQ:HUMAHumacyte Inc
 Showing the most relevant articles for your search:NASDAQ:HUMA

Su Consulta Reciente

USOTC
GLLNY
Galenica (PK)
USOTC
CIEZF
Corporacion Interamer Ent (CE)
USOTC
VSQTF
Victory Square Technolog... (QB)
LSE
95BE
Holmes Reg S
BITMOT
913246
Oat Tf 0% Fb25 Eur
USOTC
CYMHF
Cymat Technologes (QB)
LSE
LC12
Hsbc Hldg 27
EU
Y161S
Y161S
COIN
GDMUST
GOLDMONEY
USOTC
REMRF
Atlas Salt (QB)
ASX
IAUN
LSE
FEML
Fidelity Emerging Markets
LSE
TRMS
LSE
BC60
Hsbc Bk.24
USOTC
CNCSF
China Castson 81 Finance (PK)
BIT
UR9ZQ9
UniCredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados